“Our group’s strategic approach for development and protection of our intellectual property is built on a foundational understanding that IP is amongst our greatest assets. We have developed a unique, multi-tiered IP strategy which aims to advance the group’s business goals and obtain a strong competitive advantage through offensive and defensive positions.”
David Prutchi, who joined the group in 1997, holds an MSc and PhD in Biomedical Engineering from Tel-Aviv University. He is the lead author of Design and Development of Medical Electronic Instrumentation – A Practical Perspective of the Design, Construction and Test of Medical Devices (Wiley-Interscience, 2004) and co-author of Exploring Quantum Physics Through Hands-On Projects (Wiley, 2012).
Shawn Moaddeb is an entrepreneur with over 25 years’ experience in the medical device industry. Shawn was VP of RF Technology at Vessix Vascular and he is a named inventor on over 100 issued and pending patents in the areas of RF catheter-based renal denervation, percutaneous mitral valve catheter-based therapy, electrophysiology and cardiac ablation systems, medical laser systems, GI, and implantable pacemaker and defibrillator devices.
Shlomo Ben-Haim, the founder of Hobart Group, is an entrepreneur in the field of medical technology with a long and successful record of exits. Educated in the fields of nuclear physics, mathematics, biophysics, philosophy and medicine, Professor Ben-Haim has held faculty appointments as Professor of Medicine, Physiology and Biophysics at Harvard University and the Technion ‒ Israel Institute of Technology.